Atherogenic lipid fractions are related to ionized magnesium status

American Journal of Clinical Nutrition

Volumn 67, Issue 2, 1998, Pages 202-207

  Haenni, Arvo ^a,b   Öhrvall, Margareta ^a   Lithell, Hans ^a  

^a Department of Geriatrics ^*  (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

Author keywords

Apolipoprotein; Cholesterol; Elderly men; Glucose; Insulin; Ionized magnesium; Ischemic heart disease

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; CHOLESTEROL; GLUCOSE; INSULIN; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MAGNESIUM ION; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN CHOLESTEROL;

AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; HUMAN; HUMAN EXPERIMENT; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; MAGNESIUM BLOOD LEVEL; MALE; NORMAL HUMAN; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0031933842     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/67.2.202     Document Type: Article

References (30)

1. Maseroni R, Piza Z, Clayton D. Myocardial infarction and water hardness in the WHO myocardial infarction registry network. Bull World Health Organ 1979;57:291-9.
2. Karppanen H. Epidemiological studies on the relationship between magnesium intake and cardiovascular diseases. Artery 1981;9:190-9.
3. Rayssiguier Y. Magnesium, lipids and vascular diseases. Magnesium 1986;5:182-90.
4. Gueux E, Cubizolles C, Bussiere L, Mazur A, Rayssiguier Y. Oxidative modification of triglyceride-rich Hpoproteins in hypertriglyceridemic rats following magnesium deficiency. Lipids 1993;28:573-5.
5. Caddell JL. Effect of dietary protein and magnesium on plasma cholesterol in weanling rats. Pediatr Res 1977;11:511 (abstr).
6. Caddell JL. Effect of dietary protein and magnesium on plasma triglycerides in weanling rats. Pediatr Res 1977;11:512 (abstr).
7. Yokoyama S, Gu J, Kashima K, Nishida HI, Smith TL, Kummerow FA. Combined effects of magnesium deficiency and the atherogenic level of low density lipoprotein on uptake and metabolism of low density lipoprotein by cultured human endothelial cells. Magnes Res 1994;7:97-105.
8. Ouchi Y, Tabata R, Stergiopoulos K, Sato F, Hattori A, Orimo H. Effect of dietary magnesium on development of atherosclerosis in cholesterol-fed rabbits. Arteriosclerosis 1990;10:732-7.
9. Sjögren A, Floren C, Nilsson Å. Magnesium deficiency in IDDM related to level of glycosylated hemoglobin. Diabetes 1986;35:459-63.
10. Howard B. Lipoprotein metabolism in diabetes mellitus. J Lipid Res 1987;28:613-28.
11. Garcia M, McNamara P, Gordon T, Kannell WB. Sixteen year follow-up study. Morbidity and mortality in diabetics in the Framingham study. Diabetes 1976;23:105-11.
12. Speich M, Gelot S, Auget J. Plasma and erythrocyte magnesium, calcium, zinc, copper, phosphorus and cholesterols in a population of 1050 healthy adults. Magnes Bull 1995;17:62-9.
13. Walser M. Magnesium metabolism. Rev Physiol Biochem Pharmacol 1967;59:185-296.
14. Maj-Zurawska M, Lewenstam A. Fully automated potentiometric determination of ionised magnesium in blood serum. Anal Chim Acta 1990;236:331-5.
15. DeFronzo R, Tobin J, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979;237:214-33.
16. Pollare T, Vessby B, Lithell H. Lipoprotein lipase activity in skeletal muscle is related to insulin sensitivity. Arterioscler Thromb 1991;11:1192-203.
17. Ikkos D, Luft R. On the intravenous tolerance test. Acta Endocrinol (Copenh) 1957;25:312-34.
18. KONE. Users manual to KONE microlyte with magnesium. Espoo, Finland: Kone Instruments, 1993.
19. Ising H, Bertschat F, Günther T, Jeremias E, Jeremias A. Measurement of free magnesium in blood, serum and plasma with an ionselective electrode. Eur J Clin Chem Clin Biochem 1995;33:365-71.
20. Henrotte JG, Durlach J. Magnésium et biométrie humaine. Variabilité physiologique de la teneur en magnésium de l'organisme. (The physiological variability in magnesium concentrations in the organism.) First international symposium on magnesium deficit in human pathology. Vittel, France: SGEMV, 1971:91-109 (in French).
21. 2+ in whole blood, serum, and plasma. Methods Find Exp Clin Pharmacol 1992;14:297-304.
22. Altura BT, Altura BM. Ionized magnesium measurements in serum, plasma and whole blood in health and disease. In: Smetana R, ed. Advances in magnesium research: magnesium in cardiology. London: John Libby, 1997:538-46.
23. Kazda A, Stern P, Nekvasilova H, Hendl J. Relationship of magnesium and selected biochemical parameters in clinical practice. In: Smetana R, ed. Advances in magnesium research: magnesium in cardiology. London: John Libby, 1997:547-52.
24. Gueux E, Mazur A, Cardot P, Rayssiguier Y. Magnesium deficiency affects plasma lipoprotein composition in rats. J Nutr 1991;121:1222-7.
25. Rasmussen HS, Aurup P, Goldstein K, et al. Influence of magnesium substitution therapy on blood lipid composition in patients with ischemic heart disease. A double-blind, placebo controlled study. Arch Intern Med 1989;149:1050-3.
26. Golf SW, Riediger H, Matines S, et al. Effects of magnesium treatment on hyperlipidemia. Magnes Bull 1990;12:138-43.
27. Corica F, Allegra A, DiBenedetto A, et al. Effects of magnesium supplementation on plasma lipid concentrations in patients with non-insulin-dependent diabetes mellitus. Magnes Res 1994;7:43-7.
28. Kisters K, Spieker C, Tepel M, Zidek W. New data about the effects of oral physiological magnesium supplementation on several cardiovascular risk factors (lipids and blood pressure). Magnes Res 1993;6:355-60.
29. Paolisso G, Sgambato S, Pizza G, Passariello N, Varricchio M, D'Onofrio F. Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects. Diabetes Care 1989;12:265-9.
30. Zofkova I, Zamrazil V, Simeckova A. Acute hypermagnesaemia retards glucose assimilation and inhibits insulin secretion during an intravenous glucose tolerance test (IVGTT). Horm Metab Res 1988;20:120-1.